ARE - Alexandria Real Estate Equities
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0152711091
Life Science, Real Estate, Research Facilities, Offices, Laboratories
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a leading life science real estate investment trust (REIT) that has made a significant impact on the world since its founding in 1994. As a pioneer in the life science real estate niche, the company has established itself as the premier owner, operator, and developer of collaborative life science mega campuses in top innovation hubs across North America.
With a market capitalization of $34.4 billion, Alexandria's portfolio consists of 74.1 million square feet of properties, including 42.2 million square feet of operating properties, 5.3 million square feet of properties under construction, and a pipeline of future development projects. The company's properties are strategically located in AAA innovation cluster locations, such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.
Alexandria's unique business model focuses on creating dynamic and collaborative environments that foster innovation, productivity, and success among its tenants. The company's properties are designed to provide tenants with access to cutting-edge facilities, state-of-the-art amenities, and a network of like-minded companies and researchers. This approach has enabled Alexandria to attract a high-quality and diverse tenant base, resulting in higher occupancy levels, longer lease terms, and higher rental income.
In addition to its real estate business, Alexandria also provides strategic capital to transformative life science companies through its venture capital platform. This platform enables the company to support innovative startups and early-stage companies, further solidifying its position as a leader in the life science industry.
With a proven track record of developing Class A/A+ properties and a commitment to making a positive and lasting impact on the world, Alexandria Real Estate Equities, Inc. is well-positioned for continued growth and success in the life science real estate market. For more information, please visit https://www.are.com.
Drawdown (Underwater) Chart
![Drawdown / Underwater Chart for ARE - Alexandria Real Estate Equities](https://www.valueray.com/images/drawdown_chart/ARE.NYSE_drawdown.png)
Overall Trend and Yearly Seasonality
![Drawdown / Underwater Chart for ARE - Alexandria Real Estate Equities](https://www.valueray.com/images/chart/ARE.NYSE_seasonality.png)
ARE Stock Overview
Market Cap in USD | 21,897m |
Sector | Real Estate |
Industry | REIT - Office |
GiC SubIndustry | Diversified REITs |
TER | 0.00% |
IPO / Inception | 1997-05-27 |
ARE Stock Ratings
Growth 5y | -4.61 |
Fundamental | -4.50 |
Dividend | 65.9 |
Rel. Performance vs Sector | -0.84 |
Analysts | 4.62/5 |
Fair Price Momentum | 113.96 USD |
Fair Price DCF | 34.48 USD |
ARE Dividends
Dividend Yield 12m | 4.27% |
Yield on Cost 5y | 4.13% |
Dividends CAGR 5y | 4.40% |
Payout Consistency | 95.8% |
ARE Growth Ratios
Growth 12m | -1.77% |
Growth Correlation 12m | 27% |
Growth Correlation 3m | 8% |
CAGR 5y | -0.67% |
CAGR/Mean DD 5y | -0.03 |
Sharpe Ratio 12m | -0.21 |
Alpha vs SP500 12m | -23.54 |
Beta vs SP500 5y weekly | 1.06 |
ValueRay RSI | 34.26 |
Volatility GJR Garch 1y | 33.10% |
Price / SMA 50 | 0.55% |
Price / SMA 200 | 3.01% |
Current Volume | 920.1k |
Average Volume 20d | 920.6k |
External Links for ARE Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of July 27, 2024, the stock is trading at USD 118.92 with a total of 920,099 shares traded.
Over the past week, the price has changed by -5.02%, over one month by +3.96%, over three months by +3.46% and over the past year by -1.12%.
According to ValueRays Forecast Model, ARE Alexandria Real Estate Equities will be worth about 123.8 in July 2025. The stock is currently trading at 118.92. This means that the stock has a potential upside of +4.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 143.7 | 20.8 |
Analysts Target Price | 145.4 | 22.3 |
ValueRay Target Price | 123.8 | 4.10 |